Home › Funds › Ishara Investments LP › MNPR

Ishara Investments LP position in MNPR

MONOPAR THERAPEUTICS INC · Health Care

Ishara Investments LP reported holding 12,000 shares of MNPR (MONOPAR THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$956K, representing 0.81% of its reported portfolio and ranking #32 among its reported holdings. Ishara Investments LP has disclosed MNPR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)12.00K sh
Reported value held$956.04K
Portfolio Weight0.81%
First reportedQ2 2026
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Ishara Investments LP's MNPR position evolved

Ishara Investments LP first disclosed a stake in MNPR in Q2 2026 at 12,300 shares (US$1.1M). Across 2 filings, Ishara Investments LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 12,000 shares valued at US$956K — a reduction of -300 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 12.30K $1.14M New
Q3 2026 12.00K $956.04K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MNPR and 13F data

MNPR (MONOPAR THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in MNPR — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$61.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$30.0M), Saturn V Capital Management LP (US$24.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MNPR

All MNPR fund holders →

FAQ

How long has Ishara Investments LP held MNPR?

Ishara Investments LP has disclosed MNPR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Ishara Investments LP's current position in MNPR?

As of Q3 2026, Ishara Investments LP holds 12.00K shares of MNPR (MONOPAR THERAPEUTICS INC), valued at $956.04K, representing 0.81% of its reported portfolio and ranking #32.

Has Ishara Investments LP been buying or selling MNPR?

In the latest 13F filing (Q3 2026), Ishara Investments LP reduced its position in MNPR.

Which other funds hold MNPR?

Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P., Saturn V Capital Management LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.